0 Replies
Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not 'druggable' with small molecules or protein-based therapies. There are today 51 ... Contine Reading & Discuss→
0 Replies
Extra value: One year of free online updates included with this product Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not 'druggable' ... Contine Reading & Discuss→
0 Replies
This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis. The report ... Contine Reading & Discuss→
0 Replies
This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis. The report ... Contine Reading & Discuss→
0 Replies
RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic applications ... Contine Reading & Discuss→
0 Replies
RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic applications ... Contine Reading & Discuss→
0 Replies
... Treatment of respiratory syncytial virus (rsv) infection 158dec 05, 2006: alnylam advances a systemically delivered rnai therapeutic targeting pcsk9 for the treatment of hypercholesterolemia as new ... Contine Reading & Discuss→
0 Replies
... Nucleotide rnas termed sirnas that are used in a sequence-specific manner to recognize and destroy complementary rna. The report compares rnai with other antisense approaches using oligonucleotides, aptamers ... Contine Reading & Discuss→
